top of page
FINAL_Milan26_WebBanner_1920x400px.jpg

Programme

The programme will be available shortly

Friday 17 July

08:30-09:00

Registration

09:00-13:00

ICLE SITGEC joined session​

TBC

13:00-14:00

Registration (for those who only attend the afternoon session)

& lunch (only for those who attended the morning session)​

14:00-16:10

14:00-14:10: Welcome address

​

Session 1 | Emerging tools and cell engineering approaches.​​​

14:10-14:30: Monica Casucci, OSR, Milan

INV01: CAR-T cells for CCL metastasis​

​​

14:30-14:50: Cecilia Cotta Ramusino, Tessera Tx

INV02: Technology & in vivo editing (HSCs and T cells)​

​

14:50 - 15:10: Angelo Lombardo, SR Tiget, Milan

INV03: T cell engineering by polyfunctional editing

​

15:10 - 15:30: Daniele Canarutto, SR Tiget, Milan

INV04: Selection strategies & RAG1

​

15:30 - 15:50: Anna Cereseto, Uni Trento

INV05: New editing tools

​

15:50 - 16:10: Marcello Maresca, Astra- Zeneca

​INV06: TBC​​

16:10-16:40

Coffee Break​​

16:40-18:40

Session 2 | Gene correction strategies and clinical trials updates.

16:40 - Annarita Miccio, Insitut Imagine, Paris

INV07: Editing strategies for b-Hemoglobinopathies​

​

17:00 - Mario Amendola, Genethon, Paris

INV08: TBC

​

17:20 - Vincenzo Cerullo, University of Helsinki

INV09: Cancer vaccines

​

17:40 - Alessandro Aiuti, SR-Tiget, Milan

INV10: HSC-based gene therapy

​

18:00 - Nicola Brunetti-Pierri, Tigem Naples

INV11: AAV-mediated liver gene therapy

​

18:20 - Michele De LucaUniversity of Modena

INV12: Epidermolysis bullosa GT​

19:00- 23:00

Networking event and party

Saturday 18 July

08:30-09:00

Registration

09:00-10:20

Session 3 | Safety and responses to gene therapy

09:00 - Daniela Cesana, SR-Tiget, Milan

INV13: Safety and Efficacy Monitoring

​

09:20 - Anna Kajaste-Rudnitski, University of Padova

INV14: Impact of cell-autonomous immune responses in gene therapy

​

09:40 - Giandomenico Turchiano, Astra-Zeneca

INV15: Genome integrity in editing

​

10:00 - Silvia Gregori, SR-Tiget, Milan

INV16: Dissecting and harnessing immune responses in GT

10:20-10:50

Coffee Break

10:50-12:30

Session 4 | In vivo pre-clinical gene therapy

10:50 - Alessio Cantore, SR-Tiget, Milan

INV17: Liver GT for metabolic disease

​​

11:10 - Pasquale Piccolo, Tigem, Naples

INV18: Liver GT and fibrosis

​

11:30 - Ivana Trapani, Tigem, Naples

INV18: Retina GT

​

11:50 - Mauro Giacca, King's College, London

INV19: Cardiac GT

​

12:10 - Vania Broccoli, OSR, Milan

INV20: CNS GT 

12:30-13:30

Session 5 | Selected abstract

4 selected abstracts

13:30-13:45

Closing remarks

17 July
18 July
bottom of page